The vision of The Andrew M. and Jane M. Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs) is to become a leader in the field of human immunology by establishing an environment where basic, translational and clinical aspects of human immunology and immunotherapy research are seamlessly integrated. We will achieve this through these primary initiatives:
- Facilitate basic research in the new and rapidly evolving areas of human immunology;
- Use the insights that emerge from this research to achieve a better understanding of human disease; and,
- Provide an environment that encourages and supports the clinical translation of these insights into novel therapies for autoimmunity, cancer, immunodeficiency and infectious diseases.
COVID-19 IML Update
The IML is currently open with restrictions. The IML is supporting COVID projects as well as non-COVID, IML staff operated services with limited availability. Social distancing and sanitation procedures will be followed. Non-staff members will not be admitted to the IML. Self-use instrumentation is only available at off hours when IML staff are not present. All work should continue to be scheduled and approved through iLab.
We are sorry for any inconvenience and ask that everyone considers the health of their staff, students, and community by cooperating with the Dean’s request to limit research activity at this time.
CHiiPs Faculty Membership
As a member of CHiiPs, you have full access to the Immunomonitoring Lab (IML), experts in cytometry and immunoassay production, and extensive resources; even better, CHiiPs members receive a substantial discounted rate for some of these services.
iLab User Registration
iLab is a web-based system that utilizes a user’s existing WUSTL Key login information to place requests for core lab services, schedule equipment and monitor progress of current and ongoing projects serviced by the Immunomonitoring
Lab (IML). PI approval needed for new users.